NACL Industries Q1 profit rises 65%; EBITDA margin expands to 10.8%
NACL Industries Limited reported a standalone net profit of ₹23.57 crore for Q1FY27, a 64.8% increase from the previous year. EBITDA margin expanded to 10.8% while consolidated net profit rose to ₹20.84 crore. The Board approved the divestment of its stake in Nasense Labs Private Limited for ₹8,15,29,967.

*this image is generated using AI for illustrative purposes only.
NACL Industries Limited reported a standalone net profit of ₹23.57 crore for the quarter ended June 30, 2026, marking a 64.8% increase from ₹14.30 crore in the corresponding period of the previous year. Revenue from operations for Q1FY27 stood at ₹382.25 crore, while total income was ₹384.26 crore. The Board of Directors approved the unaudited financial results on July 22, 2026.
Financial Performance
The company's EBITDA for the quarter stood at ₹414 million, up from ₹381 million in the same period last year, reflecting improved operational efficiency. EBITDA margin expanded meaningfully to 10.8% from 8.51% on a year-on-year basis. On a consolidated basis, net profit rose to ₹20.84 crore from ₹13.04 crore in Q1FY26, while consolidated revenue from operations was ₹383.33 crore compared to ₹448.36 crore in the prior year period. The basic and diluted earnings per share (EPS) for the standalone entity were recorded at ₹1.01 for the quarter, up from ₹0.66 in the same period last year.
The table below summarises the key financial metrics for the quarter:
| Metric | Standalone Q1FY27 (₹ in Lakhs) | Standalone Q1FY26 (₹ in Lakhs) | Consolidated Q1FY27 (₹ in Lakhs) | Consolidated Q1FY26 (₹ in Lakhs) |
|---|---|---|---|---|
| Revenue from Operations | 38,225 | 43,850 | 38,333 | 44,836 |
| Total Income | 38,426 | 44,077 | 38,522 | 44,953 |
| Net Profit | 2,357 | 1,430 | 2,084 | 1,304 |
| Basic EPS (₹) | 1.01 | 0.66 | 0.89 | 0.60 |
| EBITDA Metric | Q1FY27 | Q1FY26 |
|---|---|---|
| EBITDA | ₹414 million | ₹381 million |
| EBITDA Margin | 10.80% | 8.51% |
Strategic Divestment
The Board approved the proposal to divest the company's entire equity stake in Nasense Labs Private Limited, an associate company. The stake will be sold to Mr. Kanumuru Satyanarayana Raju for a total consideration of ₹8,15,29,967. The transaction is expected to be completed within the next three months, subject to the fulfilment of terms and conditions outlined in the Share Purchase Agreement. Post-completion, Nasense Labs Private Limited will cease to be an associate company of NACL Industries Limited.
Operational Details
The unaudited financial results were reviewed by M/s. S R Batliboi & Associates, Statutory Auditors of the company, who issued an unmodified conclusion. The company also reported that funds raised through a rights issue in December 2025 have been utilised for the intended purposes, with an unutilised amount of ₹2,445 lakhs deposited in an earmarked bank account. Additionally, the company allotted 65,000 equity shares during the quarter pursuant to the exercise of stock options.
Historical Stock Returns for NACL Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -6.12% | -13.73% | -10.88% | +17.13% | -39.52% | +168.16% |
How does NACL Industries plan to utilize the proceeds from the divestment of Nasense Labs?
Can the expansion in EBITDA margins be sustained throughout the remainder of FY27?
What specific capital expenditures or growth initiatives will the unutilized rights issue funds of ₹2,445 lakhs support?


































